Form D · Other Health Care

Element Science, Inc.

San Francisco, CA · CIK 0001602935

Offering snapshot reported Mar 12, 2020 · SEC filing

Reported sold
$50.6M
Offering amount: $146M
Investors reported
11
Form D · investor count
Minimum accepted
$1
Reported outside-investor minimum
First sale
Mar 3, 2020
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Mar 12, 2020Initial$50,649,148No comparison11SEC filing
Jun 6, 2019Amendment$9,500,000$1,000,000vs May 3, 20192SEC filing
May 3, 2019Amendment$8,500,000$7,000,000vs Sep 20, 20182SEC filing
Sep 20, 2018Initial$1,500,000No comparison2SEC filing
Aug 22, 2016Initial$24,999,993No comparison1SEC filing
Mar 19, 2014Initial$12,499,998No comparison2SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-362698

Source: Form D, filed Mar 12, 2020. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Andrew El Bardissi Director
Neil Exter Director
Russell Hirsch Director
William Kucheman Director
Uday N. Kumar Director, Executive
Christopher Shen Director
Benjamin Tsai Director
Krishna Yeshwant Director

Issuer details

Industry: Other Health Care (See others in industry)

Address:
200 Kansas Street Suite 210
San Francisco, CA, 94103